Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Payables: 2019-2024

Historic Payables for Legend Biotech (LEGN) over the last 6 years, with Dec 2024 value amounting to $38.6 million.

  • Legend Biotech's Payables rose 25.90% to $38.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $102.2 million, marking a year-over-year increase of 39.42%. This contributed to the annual value of $38.6 million for FY2024, which is 25.90% up from last year.
  • Legend Biotech's Payables amounted to $38.6 million in FY2024, which was up 25.90% from $30.7 million recorded in FY2023.
  • Legend Biotech's Payables' 5-year high stood at $38.6 million during FY2024, with a 5-year trough of $4.9 million in FY2020.
  • Its 3-year average for Payables is $34.0 million, with a median of $32.9 million in 2022.
  • In the last 5 years, Legend Biotech's Payables plummeted by 48.77% in 2020 and then surged by 367.03% in 2022.
  • Legend Biotech's Payables (Yearly) stood at $4.9 million in 2020, then spiked by 43.41% to $7.0 million in 2021, then spiked by 367.03% to $32.9 million in 2022, then decreased by 6.80% to $30.7 million in 2023, then increased by 25.90% to $38.6 million in 2024.